Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the Northern District of West ...

Calling climate change the "biggest problem" facing the world, Bilawal highlighted the severe risks it poses to future generations. He pointed out that Sindh had already witnessed the catastrophic ...